SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first…
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first…
NEW YORK--(BUSINESS WIRE)--In response to the recent executive budget decision by Governor Kathy Hochul, which includes a substantial $125 million…
PHILADELPHIA, PA / ACCESSWIRE / February 23, 2024 / CGFNS International announced today it has established a Global Health Workforce…
SOMERSET, NJ / ACCESSWIRE / February 23, 2024 / Americord, a leading private stem cell bank, announced the release of…
Company closed financing of $8.0 million with an additional $8.0 million second tranche tied to milestones for aggregate proceeds of…
STOCKHOLM, SWEDEN / ACCESSWIRE / February 23, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") is pleased to…
LOS ANGELES, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Today, Curai Health, a virtual clinic, announced that it is expanding access to…
"MMJ International Holdings has manufactured a botanical extract in a final dose form gel cap and will investigate its novel…
COLUMBIA, MD / ACCESSWIRE / February 22, 2024 / Nava Health, a pioneer in integrative and functional medicine, is thrilled…